Forbes January 21, 2025
Steve Brozak

Last week, the San Francisco Department of Public Health (SFDPH) confirmed that a child in the city became the first case of Avian Influenza-Bird Flu (H5N1). With the Biotech Showcase™ conference running in the city at the same time, it was timely that a panel of healthcare experts and biotech industry leaders discussed what options could be taken to deal with the spread of this virus and its consequences. What follows is a synopsis of the central points:

The panel began with the NGO, Coalition for Epidemic Preparedness Innovations (CEPI)’s Executive Director, Emma Wheatley answering the question: Are we destined to forever chase outbreaks? What can we do stay one step ahead and deal with the spread while also preventing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
The U.S. Government and the World Health Organization - 2
Moderna gets $590M from US government for bird flu vaccine
CDC: Flu activity remains high, COVID-19 increasing while RSV peaks
Donald Trump’s first steps on healthcare: Inaugural remarks, leaving the WHO, and more
This virologist researches how we fight viruses such as Covid-19

Share This Article